A systematic review of morbidities suggestive of the multiple sclerosis prodrome

References

• Mckay KA, Jahanfar S, Duggan T, et al. Factors associated with onset, relapses or progression in multiple sclerosis: a systematic review. Neurotoxicology. 2017;61:189–212.
   PubMed Web of Science ®Google Scholar
• Brownlee WJ, Miller DH. Clinically isolated syndromes and the relationship to multiple sclerosis. J Clin Neurosci. 2014;21:2065–2071.
   PubMed Web of Science ®Google Scholar
• Multiple Sclerosis International Federation. Atlas of MS 2013: mapping multiple sclerosis around the world. Mult Scler Int Fed. 2013;1-28.
   Google Scholar
• Ramagopalan SV, Dobson R, Meier UC, et al. Multiple sclerosis: risk factors, prodromes, and potential causal pathways. Lancet Neurol. 2010;9:727–739.
   PubMed Web of Science ®Google Scholar
• Cortese M, Riise T, Bjørnevik K, et al. Preclinical disease activity in multiple sclerosis: a prospective study of cognitive performance prior to first symptom. Ann Neurol. 2016;80:616–624.
   PubMed Web of Science ®Google Scholar
• Wijnands JMA, Kingwell E, Zhu F, et al. Health-care use before a first demyelinating event suggestive of a multiple sclerosis prodrome: a matched cohort study. Lancet Neurol. 2017;16:445–451.
   PubMed Web of Science ®Google Scholar
• Wijnands JM, Zhu F, Kingwell E, et al. Five years before multiple sclerosis onset: phenotyping the prodrome. Mult Scler J. 2019;25:1092–1101.
   PubMed Web of Science ®Google Scholar
• Högg T, Wijnands JMA, Kingwell E, et al. Mining healthcare data for markers of the multiple sclerosis prodrome. Mult Scler Relat Disord. 2018;25:232–240.
   PubMedGoogle Scholar
• Fava GA, Kellner R. Prodromal symptoms in affective disorders. Am J Psychiatry. 1991;148:823–830.
   PubMed Web of Science ®Google Scholar
• Okuda DT, Mowry EM, Beheshtian A, et al. Incidental MRI anomalies suggestive of multiple sclerosis. Neurology. 2009;72:800–805.
   PubMed Web of Science ®Google Scholar
• Tremlett H, Marrie RA. The multiple sclerosis prodrome: emerging evidence, challenges and opportunities (Viewpoint). Mult Scler J. 2020 Mar 31:1352458520914844. doi:10.1177/1352458520914844. [Epub ahead of print].
   Google Scholar
• Forslin Y, Granberg T, Jumah AA, et al. Incidence of radiologically isolated syndrome: a population-based study. Am J Neuroradiol. 2016;37:1017–1022.
   PubMed Web of Science ®Google Scholar
• Larson MK, Walker EF, Compton MT. Early signs, diagnosis and therapeutics of the prodromal phase of schizophrenia and related psychotic disorders. Expert Rev Neurother. 2010;10(8):1347–1359. NIH Public Access.
   PubMed Web of Science ®Google Scholar
• Noyce AJ, Lees AJ, Schrag AE. The prediagnostic phase of Parkinson’s disease. J Neurol Neurosurg Psychiatry. 2016;87:871–878. [ BMJ Publishing Group].
   PubMed Web of Science ®Google Scholar
• Marrie RA, Reider N, Cohen J, et al. A systematic review of the incidence and prevalence of sleep disorders and seizure disorders in multiple sclerosis. Mult Scler J. 2015;21:342–349.
   PubMed Web of Science ®Google Scholar
• Systematic Reviews: CRD’s guidance for undertaking reviews in health care [Internet]. Available from: https://www.york.ac.uk/media/crd/Systematic_Reviews.pdf
   Google Scholar
• Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BM. 2009;339:b2700.
   PubMed Web of Science ®Google Scholar
• Thacker EL, Mirzaei F, Ascherio A. Infectious mononucleosis and risk for multiple sclerosis: a meta-analysis. Ann Neurol. 2006;59:499–503.
   PubMed Web of Science ®Google Scholar
• Warren SA, Olivo SA, Contreras JF, et al. Traumatic injury and multiple sclerosis: a systematic review and meta-analysis. Can J Neurol Sci/J Can Des Sci Neurol. 2013;40:168–176.
   Google Scholar
• Wells G, Shea B, O’Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses [Internet]. [ cited 2019 May 12]. Available from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp
   Google Scholar
• Luchini C, Stubbs B, Solmi M, et al. Assessing the quality of studies in meta-analyses: advantages and limitations of the Newcastle Ottawa Scale. World J Meta-Analysis. 2017;5:80.
   Google Scholar
• Thormann A, Koch-Henriksen N, Laursen B, et al. Inverse comorbidity in multiple sclerosis: findings in a complete nationwide cohort. Mult Scler Relat Disord. 2016;10:181–186.
   PubMed Web of Science ®Google Scholar
• Hedström AK, Olsson T, Alfredsson L. High body mass index before age 20 is associated with increased risk for multiple sclerosis in both men and women. Mult Scler J. 2012;18:1334–1336.
   PubMed Web of Science ®Google Scholar
• Tarrats R, Ordonez G, Rios C, et al. Varicella, ephemeral breastfeeding and eczema as risk factors for multiple sclerosis in Mexicans. Acta Neurol Scand. 2002;105:88–94.
   PubMed Web of Science ®Google Scholar
• Alonso A, Jick SS, Hernan MA. Allergy, histamine 1 receptor blockers, and the risk of multiple sclerosis. Neurology. 2006;66:572–575.
   PubMed Web of Science ®Google Scholar
• Alonso A, Hernán MA, Ascherio A. Allergy, family history of autoimmune diseases, and the risk of multiple sclerosis. Acta Neurol Scand. 2008;117:15–20.
   PubMed Web of Science ®Google Scholar
• Zorzon M, Zivadinov R, Nasuelli D, et al. Risk factors of multiple sclerosis: a case-control study. Neurol Sci. 2003;24:242–247.
   PubMed Web of Science ®Google Scholar
• Karimi P, Modarresi SZ, Sahraian MA, et al. The relation of multiple sclerosis with allergy and atopy: a case control study. Iran J Allergy Asthma Immunol. 2013;12:182–189.
   PubMed Web of Science ®Google Scholar
• Sinay V, Perez Akly M, Zanga G, et al. School performance as a marker of cognitive decline prior to diagnosis of multiple sclerosis. Mult Scler J. 2015;21:945–952.
   PubMed Web of Science ®Google Scholar
• Mansouri B, Asadollahi S, Heidari K, et al. Risk factors for increased multiple sclerosis susceptibility in the Iranian population. J Clin Neurosci. 2014;21:2207–2211.
   PubMed Web of Science ®Google Scholar
• Ponsonby A-L, Dwyer T, van der Mei I, et al. Asthma onset prior to multiple sclerosis and the contribution of sibling exposure in early life. Clin Exp Immunol. 2006;146:463–470.
   PubMed Web of Science ®Google Scholar
• Antonovsky A, Leibowitz U, Smith HA, et al. Epidemiologic study of multiple sclerosis in Israel. Arch Neurol. 1965;13:183.
   PubMedGoogle Scholar
• Sahraian MA, Jafarian S, Sheikhbahaei S, et al. Respiratory tract rather than cutaneous atopic allergy inversely associate with multiple sclerosis: a case–control study. Clin Neurol Neurosurg. 2013;115:2099–2102.
   PubMed Web of Science ®Google Scholar
• Pedotti R, Farinotti M, Falcone C, et al. Allergy and multiple sclerosis: a population-based case-control study. Mult Scler J. 2009;15:899–906.
   PubMed Web of Science ®Google Scholar
• Disanto G, Zecca C, MacLachlan S, et al. Prodromal symptoms of multiple sclerosis in primary care. Ann Neurol. 2018;83:1162–1173.
   PubMed Web of Science ®Google Scholar
• Gunnarsson M, Udumyan R, Bahmanyar S, et al. Characteristics in childhood and adolescence associated with future multiple sclerosis risk in men: cohort study. Eur J Neurol. 2015;22:1131–1137.
   PubMed Web of Science ®Google Scholar
• National Library of Medicine. RCD (Read Codes) [Internet]. Natl Libr Med. Available from. https://www.nlm.nih.gov/research/umls/sourcereleasedocs/current/RCD/index.html
   Google Scholar
• Hedström A, Olsson T, Alfredsson L. Body mass index during adolescence, rather than childhood, is critical in determining MS risk. Mult Scler J. 2016;22:878–883.
   PubMed Web of Science ®Google Scholar
• Hoang H, Laursen B, Stenager EN, et al. Psychiatric co-morbidity in multiple sclerosis: the risk of depression and anxiety before and after MS diagnosis. Mult Scler J. 2016;22:347–353.
   PubMed Web of Science ®Google Scholar
• Marrie RA, Patten SB, Tremlett H, et al. Sex differences in comorbidity at diagnosis of multiple sclerosis. Neurology. 2016;86:1279–1286.
   PubMed Web of Science ®Google Scholar
• Souberbielle BE, Martin-Mondiere C, O’Brien ME, et al. A case-control epidemiological study of MS in the Paris area with particular reference to past disease history and profession. Acta Neurol Scand. 2009;82:303–310.
   Google Scholar
• Ghadirian P, Dadgostar B, Azani R, et al. A case-control study of the association between socio-demographic, lifestyle and medical history factors and multiple sclerosis. Can J Public Health. 2001;92:281–285.
   PubMed Web of Science ®Google Scholar
• Langer-Gould A, Albers K, Van Den Eeden S, et al. Autoimmune diseases prior to the diagnosis of multiple sclerosis: a population-based case-control study. Mult Scler J. 2010;16:855–861.
   PubMed Web of Science ®Google Scholar
• Fellner A, Dano M, Regev K, et al. Multiple sclerosis is associated with psoriasis. A case-control study. J Neurol Sci. 2014;338:226–228.
   PubMed Web of Science ®Google Scholar
• Thormann A, Magyari M, Koch-Henriksen N, et al. Vascular comorbidities in multiple sclerosis: a nationwide study from Denmark. J Neurol. 2016;263:2484–2493.
   PubMed Web of Science ®Google Scholar
• Vacca G, Marano E, Brescia Morra V, et al. Multiple sclerosis and headache co-morbidity. A case-control study. Neurol Sci. 2007;28:133–135.
   PubMed Web of Science ®Google Scholar
• Warren S, Warren KG. Multiple sclerosis and associated diseases: a relationship to diabetes mellitus. Can J Neurol Sci/J Can Des Sci Neurol. 1981;8:35–39.
   Google Scholar
• Mirmosayyeb O, Badihian S, Manouchehri N, et al. The interplay of multiple sclerosis and menstrual cycle: which one affects the other one? Mult Scler Relat Disord. 2018;21:46–50.
   PubMed Web of Science ®Google Scholar
• Tavakol S, Shakibapour S, Bidgoli SA. The level of testosterone, Vitamin D, and irregular menstruation more important than Omega-3 in non-symptomatic women will define the fate of multiple scleroses in future. Mol Neurobiol. 2018;55:462–469.
   PubMed Web of Science ®Google Scholar
• Fiest KM, Fisk JD, Patten SB, et al. Fatigue and comorbidities in multiple sclerosis. Int J MS Care. 2016;18:96–104.
   PubMedGoogle Scholar
• Yusuf FLA, Wijnands JMA, Kingwell E, et al. Fatigue, sleep disorders, anemia and pain in the multiple sclerosis prodrome. Mult Scler J. 2020 Apr 6:1352458520908163. doi:10.1177/1352458520908163. [Epub ahead of print]
   PubMedGoogle Scholar